STAT+: Legend Biotech believes it is not a target of Chinese investigation, CEO says
The new CEO of Legend Biotech says the company has seen no indication that it…
Category: STAT China
STAT China: Lineup for Hong Kong IPO grows, and a conversation with Junshi’s Li Ning
A version of this digest first appeared in the weekly STAT China newsletter. To receive…
STAT China: A debut for CanSino Biologics and Cellular BioMed’s controversy
A version of this digest first appeared in the weekly STAT China newsletter. To receive…